Abstract:Background: Translationally controlled tumour protein (TCTP) is associated with tumor diseases, such as breast cancer, and its inhibitor can reduce the growth of tumor cells. Unfortunately, there is currently no effective medication available for treating TCTP-related breast cancer. Objective: The objective of this study was to explore the inhibitor candidates among natural compounds for the treatment of breast cancer related to TCTP protein. Methods: To explore the potential inhibitors of TCTP, we first screened out four potential inhibitors in the Traditional Chinese Medicine (TCM) for cancer based on AI virtual screening using the docking method, and then revealed the interaction mechanism of TCTP and four candidate inhibitors from TCM with molecular docking and molecular dynamics (MD) methods. method: To explore the potential inhibitors of TCTP, we firstly screened out four potential inhibitors in the major agent of the traditional Chinese herbal medicines (TCMs) for cancer based on AI Virtual Screening using the Docking method, and then revealed the interaction mechanism of TCTP and four candidate inhibitors from TCMs with molecular docking and molecular dynamics (MD) methods. Results: Based on the conformational characteristics and the MD properties of the four leading compounds, we designed the new skeleton molecules with the AI method using MolAICal software. Our MD simulations have revealed that different small molecules bind to different sites of TCTP, but the flexible regions and the signaling pathways are almost the same, and the VDW and hydrophobic interactions are crucial in the interactions between TCTP and ligands. result: Based on the conformational characteristics and the MD properties of the four leading compounds, we designed the new skeleton molecules with AI method using MolAICal software. Our MD simulations reveal that different small molecules bind to different sites of TCTP, but the flexible regions and the signaling pathways are almost the same, the VDW and hydrophobic interactions play important roles in the interactions between ligands and TCTP. Conclusion: We have proposed the candidate inhibitor of TCTP. Our study has provided a potential new method for exploring inhibitors from Traditional Chinese Medicine (TCM).

Identification of Novel Neurotensin Receptor 1 Inhibitors by Combinatorial Support Vector Machine

Combinatorial Support Vector Machines Approach for Virtual Screening of Selective Multi-Target Serotonin Reuptake Inhibitors from Large Compound Libraries

Natural Product Virtual-Interact-Phenotypic Target Characterization: A Novel Approach Demonstrated with Salvia Miltiorrhiza Extract

Identifying Novel Type Zbgs and Nonhydroxamate Hdac Inhibitors Through A Svm Based Virtual Screening Approach

Development and Experimental Test of Support Vector Machines Virtual Screening Method for Searching Src Inhibitors from Large Compound Libraries.

Identification of Novel TRPC5 Inhibitors by Pharmacophore-Based and Structure-Based Approaches

Virtual Screening of Selective Multitarget Kinase Inhibitors by Combinatorial Support Vector Machines

Classification models for predicting the bioactivity of pan-TRK inhibitors and SAR analysis

Discovery of Novel c-Jun N-Terminal Kinase 1 Inhibitors from Natural Products: Integrating Artificial Intelligence with Structure-Based Virtual Screening and Biological Evaluation

Identification of potential inhibitors of tropomyosin receptor kinase B targeting CNS-related disorders and cancers

A two-step target binding and selectivity support vector machines approach for virtual screening of dopamine receptor subtype-selective ligands.

AI-based Virtual Screening of Traditional Chinese Medicine and the Discovery of Novel Inhibitors of TCTP

Evaluation of Virtual Screening Performance of Support Vector Machines Trained by Sparsely Distributed Active Compounds

Multiple Machine Learning Methods Aided Virtual Screening of NaV 1.5 Inhibitors.

In Silico Exploration for Novel Type-I Inhibitors of Tie-2/TEK: the Performance of Different Selection Strategy in Selecting Virtual Screening Candidates.

Development of Ligand-based Big Data Deep Neural Network Models for Virtual Screening of Large Compound Libraries.

Identification of Novel Tyrosinase Inhibitors with Nanomolar Potency Using Virtual Screening Approaches

Discovery of novel nonpeptide small-molecule NRP1 antagonists: Virtual screening, molecular simulation and structural modification

Discovery of novel TRPV1 modulators through machine learning‐based molecular docking and molecular similarity searching

Exploring and Designing Potential Inhibitors of SIRT2 in Natural Products by Artificial Intelligence (AI) and Molecular Dynamics Methods

Prediction of 5-hydroxytryptamine Transporter Inhibitor based on Machine Learning